Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers aged 18 to 45 years (both inclusive)~* Body mass index (BMI) of 18.5-29.9 kg/m2 inclusive~Exclusion Criteria:~* Pregnant or lactating women~* Allergy/intolerance to any study material~* Current or recurrent disease, within 12 months of screening that could affect the metabolism of drug~* Participants who have taken any drug known to induce or inhibit hepatic drug metabolism in 30 days prior to screening~* Positive serum Hepatitis B surface antigen, Hepatitis C antibodies or Human Immunodeficiency Virus (HIV), alcohol or drug abuse~* Smokers taking \>5 cigarettes/day; prior or current use of any other nicotine containing product~* Blood donated within 3 months of screening~* Consumed n-3 rich food or beverage or n-3 fortified food or beverage within 72h prior to each study session

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Test (Type: EXPERIMENTAL): 30mL Test contains 10%w/w cod oil + 10%w/w cod liver oil in an emulsion formulation
- Control (Type: ACTIVE_COMPARATOR): 5.8mL of cod liver oil in a free flowing non-emulsified formulation

Based on this trial design, predict the completion outcome and termination type (if applicable).